Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Long-Term Investments (2016 - 2023)

AtriCure (ATRC) has disclosed Long-Term Investments for 11 consecutive years, with $7.6 million as the latest value for Q2 2023.

  • Quarterly Long-Term Investments fell 88.18% to $7.6 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $7.6 million through Jun 2023, down 88.18% year-over-year, with the annual reading at $51.5 million for FY2022, 50.63% down from the prior year.
  • Long-Term Investments for Q2 2023 was $7.6 million at AtriCure, down from $25.6 million in the prior quarter.
  • The five-year high for Long-Term Investments was $105.1 million in Q3 2021, with the low at $7.6 million in Q2 2023.
  • Average Long-Term Investments over 5 years is $40.7 million, with a median of $23.0 million recorded in 2019.
  • The sharpest move saw Long-Term Investments surged 672.59% in 2022, then crashed 88.18% in 2023.
  • Over 5 years, Long-Term Investments stood at $12.7 million in 2019, then rose by 11.86% to $14.2 million in 2020, then soared by 635.91% to $104.3 million in 2021, then crashed by 50.63% to $51.5 million in 2022, then plummeted by 85.25% to $7.6 million in 2023.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $7.6 million, $25.6 million, and $51.5 million for Q2 2023, Q1 2023, and Q4 2022 respectively.